Trinity College Dublin (TCD), in Ireland, is to be the recipient of a new specialist 3D bioprinting facility supported by a collaboration between multinational medical device and pharmaceutical company Johnson & Johnson, and the AMBER research center.
With preparations beginning in the first quarter of this year, the new 3D bioprinting laboratory is due to be opened by the close of 2018.
Professor Michael Morris, AMBER director, comments,
“THIS LAB IS THE RESULT OF A SHARED VISION TO CREATE A GLOBAL CENTER OF EXCELLENCE FOR 3D BIOPRINTING WITHIN THE CENTER,”
“This has been made possible because of the calibre of our world leading academics, state of the art equipment and supporting facilities and infrastructure.”
An intentional center of excellence
Established in 2013, AMBER stands for “Advanced Materials + BioEngineering Research”. The center is funded by Science Foundation Ireland and co-located at TCD, University College Cork and the Royal College of Surgeons in Ireland.
From 2013 – 2017, the AMBER center has seen Ireland rise through the ranks of international excellence in nanoscience and materials science research, where it was most recently ranked within the top three.
Professor Mark Ferguson, director general of Science Foundation Ireland and chief scientific adviser to the government, comments, “I very much welcome this promising collaboration between AMBER and Johnson & Johnson Services,”
“[It] builds on Ireland’s international reputation for research excellence and presents us with an important opportunity to promote the sharing of knowledge and expertise between industry and academia – in material sciences and beyond.”
Follow us on Linkedin!